当前位置：网站首页>Research Report on Chinese psoriasis drug market evaluation and investment direction (2022 Edition)

Research Report on Chinese psoriasis drug market evaluation and investment direction (2022 Edition)

2022-06-12 02:16:00 【lmcmr】

Content abstract ：

Psoriasis （Psoriasis） It is a common 、 Chronic 、 Non infectious 、 aching 、 Disfigured 、 A disabling disease is an immune inflammatory disease , It belongs to autoimmune chronic silver filings disease . As many as 1.25 Billion people suffer from psoriasis , Global incidence rate countries look at , Most common in northern Europe 、 Australian people , There are fewer people in East Asia , China has about 600 Ten thousand patients .

The treatment of psoriasis is divided into drug treatment and non drug treatment , Drug therapy also includes external medication 、 Systemic medication 、 Chinese medicine treatment 、 Biological agents . Chinese psoriasis treatment , Most patients take external drugs 、 Chemical medicine and traditional Chinese medicine , The proportion of biological agents used is small .

according to an uncompleted statistic , The global psoriasis treatment drug market has reached 92.0 Billion dollars , The scale of the domestic psoriasis drug market exceeds 40 One hundred million yuan .

Although there are many drugs approved to treat psoriasis , But because psoriasis cannot be completely cured , Existing drugs can only improve the symptoms of the disease , Therefore, the psoriasis drug market is a very promising field , Major pharmaceutical enterprises have entered this market one after another .

Chapter one Psoriasis drugs Overview of industry development

Section 1 Current status of clinical application of psoriasis drugs

In the second quarter Analysis of the characteristics of psoriasis drug industry

Chapter two 2022 In China Psoriasis drugs Analysis of industrial operation environment

Section 1 Analysis of China's macroeconomic environment

In the second quarter Analysis of the policy and regulation environment of psoriasis drugs in China

In the third quarter Analysis of the social environment of psoriasis drugs in China

The third chapter 2021-2022 In China Psoriasis drugs Operation situation analysis

Section 1 Analysis of the scale of the national psoriasis drug market

One 、 Analysis of the overall scale of the national psoriasis drug market

Two 、 Analysis on the retail scale of the national psoriasis drug market

In the second quarter China's market share of psoriasis drugs by category

One 、 National Psoriasis chemical drug analysis

Two 、 National Psoriasis biologics analysis

In the third quarter Market price analysis of major psoriasis drugs in China

One 、 Part of the retail market price of psoriasis internal medicine

Two 、 Part of the retail price of psoriasis topical drugs

Chapter four China Psoriasis drugs Research and analysis of market behavior

Section 1 Research on Chinese consumer behavior

One 、 Gender characteristics of psoriasis drug customer base

Two 、 Dosage form selection for psoriasis patients

3、 ... and 、 Efficacy of psoriasis drugs

Four 、 Use psoriasis topical medication

5、 ... and 、 Acceptable price of psoriasis medication

6、 ... and 、 Factors to consider when purchasing psoriasis drugs

In the second quarter Chinese pharmacy terminal psoriasis drug research

The fifth chapter Psoriasis drugs Analysis of R & D status

Section 1 Progress in pharmacokinetics of silver filings in China

In the second quarter Research progress of topical drugs for psoriasis

In the third quarter Research progress of psoriasis chemical drugs

The fourth quarter, Research progress of psoriasis biological agents

Chapter six 2021-2022 In China Psoriasis drugs Dynamic analysis of segment market operation

Section 1 Market analysis of compound aminopeptin tablets

In the second quarter Market analysis of carbotriol ointment

In the third quarter Avi A Capsule Market Analysis

The fourth quarter, Market analysis of tacassiol ointment

Section 5 Benvemod cream Market

Section 6 Adalimumab injection Market

Chapter vii. China Psoriasis drugs Analysis of industry market competition pattern

Section 1 Psoriasis drug pump industry “ Porter's five force model ” analysis

One 、 Competition within the industry

Two 、 Potential entrants threaten

3、 ... and 、 The threat of alternatives

Four 、 Supplier bargaining power analysis

5、 ... and 、 Analysis of the buyer's bargaining power

In the second quarter The competition pattern of Chinese psoriasis drug industry

In the third quarter Problems and strategies in the competition of Chinese psoriasis drug enterprises

One 、 Problems in the competition of Chinese psoriasis drug enterprises

Two 、 Competitive strategy of Chinese psoriasis drug enterprises

Chapter viii. China Psoriasis drugs Analysis on the competitiveness of key industrial enterprises

Section 1 Aberway

One 、 Enterprise introduction